Allergy/Imm

sponsor

Your Unread Messages

Hello, Mary O'connor
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chen JS et al. - Tacrolimus concentrations are associated with CYP3A5 genotype. This study suggested to choose the initial dosage according to the CYP3A5 genotype to obtain a better outcome and reduce the incidences of acute rejection episodes and nephrotoxicity.

Related Articles

Black renal transplant recipients have poorer long-term graft survival than CYP3A5 expressers from other ethnic groups
Nephrology Dialysis Transplantation, 10/14/09    Relevance Score: 42%

CYP3A5 polymorphism and sensitivity of blood pressure to dietary salt in Japanese men
Journal of Human Hypertension, 10/12/09    Relevance Score: 42%

CYP3A4 and CYP3A5 Polymorphisms and Blood Pressure Response to Amlodipine among African-American Men and Women with Early Hypertensive Renal Disease
American Journal of Nephrology, 11/12/09    Relevance Score: 40%

The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test
Pharmacogenetics and genomics, 10/30/09    Relevance Score: 40%

Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients
Clinical Pharmacology & Therapeutics, 10/29/09    Relevance Score: 40%

Today in Clinical Pharmacology...keeping you current

Treatment with the PPAR-gamma agonist rosiglitazone down-regulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
European Journal of Endocrinology, 11/24/09

Azelastine nasal spray for the treatment of allergic and nonallergic rhinitis
Expert Review of Clinical Immunology, 11/23/09

Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/23/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address